Reborn, back to a small county town to become a wealthy family

Chapter 821 High-Value Companies Even Reincarnated Individuals Would Miss

"Mr. Luo, you can't expect the horse to run without feeding it, can you?"

Song Wan smiled and looked at Luo Yang, saying, "It was only agreed that I would be in charge of Guobao Films, but then it changed, and they insisted on giving me an additional responsibility: to create an online community platform. Now I want to fight for some support for Guobao Films. Is that too much to ask?"

After she said that, Luo Yang could only pinch his nose in frustration.

Last Saturday, Luo Yang specifically mentioned how to retain registered users of shared bikes and combine them with platforms like C-Station and Pinduoduo to create a community platform.

Moreover, Song Wan asked Luo Yang for funds for the future development of Guobao Films, so her public-spiritedness outweighed her personal interests.

"If you could acquire a stake in Dianping.com, what would you do next?"

The soft-hearted Luo Yang stopped dwelling on the fact that his secret stash of money had been emptied, and followed up on Song Wan's words by asking, "Are you planning to start your own online ticketing platform similar to Damai?"

"In the early stages, I don't plan to imitate Damai.cn."

When it came to business, Song Wan immediately put away her relaxed expression and replied seriously, "Including Plan A, the initial reason for acquiring Damai.cn shares was to add a multiplier to the development of Guobao Films. Therefore, the main demand in the early stage was still in the film and television field. Guobao is an offline business, so it needs an online platform to complete the entire system. Therefore, the company to be established will only focus on the film and television field."

As she spoke, she gestured with her eyes to Jiang Linghan, the leader of the second group.

The previously projected PPT was immediately closed, and Jiang Linghan opened a folder on the computer screen.

"**Business Plan for a Movie Ticketing Website**"

Good heavens, Song Wan had already dug a pit, just waiting for Luo Yang to fall into it!
To Luo Yang's astonishment, Song Wan began to personally explain the plan.

"I won't go into the background and reasons for founding this online platform company, as I've already explained them before."

Unlike Jiang Linghan's tedious report, Song Wan's explanation was very concise.

The first few pages of the copy can be flipped through quickly.

"Next, I'll mainly talk about business models."

At the key point, Song Wan slowed down: "First of all, there's the ticket revenue sharing. Everyone can understand this. It involves cooperating with major cinemas to provide movie ticket booking services to users and taking a certain percentage of the revenue from each movie ticket sold. This is one of the website's important sources of income."

It's not just slow, there's more to it than that.

"Our Guobao Films already has cooperative relationships with major cinema chains in China, and as our film and television business further expands in the future, these cooperations will be further deepened."

Song Wan added, "This gave our online ticketing platform a higher starting point and made the initial cooperation relatively easier."

Although Luo Yang didn't speak, he nodded secretly.

"Secondly, there's the production and distribution of the film. We want to participate in the investment and production of the film and earn revenue through box office revenue sharing and other means."

When Song Wan mentioned this point, her face shone with pride: "This is also one of the differences between us and Damai.cn, because we have a natural platform like Guobao Films, which has rich experience and advantages in the production and distribution of film and television dramas."

"If that's the case, will your newly established online ticketing platform become an independent operation?"

Luo Yang couldn't help but interject: "After all, Guobao will also invest in other film and television works. In this way, it will seem that the two companies have overlapping functions and that resources will be wasted."

"how could be?"

Song Wan turned to Luo Yang and replied, "With so many films shot and released in China every year, how many can a single company like Guobao Films invest in?"

"That's a matter of opinion."

Luo Yang said dismissively, "There are many films released in China every year, but how many of them make money? Even if some do make money, from an investment perspective, if the profit doesn't meet a certain requirement, it's equivalent to a loss. Although there's no unified standard for this requirement yet, the two films 'Fleet of Time' and 'Lost in Thailand' will be released in the second half of the year. Adding to that the previously invested 'Love is Not Blind,' those three films should be enough to measure the standard, right?"

He's setting a trap for Song Wan.

These three films were all extremely successful, and are typical examples of films that achieved great success with limited budgets.

Although there are one or two such films released every year, Luo Yang was able to accurately identify them because of his reborn prophecy. If it were Guobao Films under Song Wan's leadership, it might not be the case.

If we were to use Luo Yang's investment returns as a benchmark, the difficulty would be immense.

Song Wan had already opened her mouth, but after seeing the fleeting smile on Luo Yang's lips, she abruptly stopped the words that were about to come out of her throat.

"Those two movies haven't been released yet."

Based on her subconscious intuition, Song Wan did not fall for the trick and instead adopted a delaying tactic: "Let's discuss this issue after the box office results of the two films are released. Until then, let's treat it as a backup plan in the business strategy."

Pity.
Luo Yang felt a slight pang of regret that he hadn't managed to get Song Wan to jump into the trap.

However, he remained silent, signaling Song Wan to continue.

"In addition, this online platform can also act as a publisher."

Song Wan gave Luo Yang a deep look, then skipped over her doubts and continued, "The newly established company will not only be an online ticketing platform, but will also act as a distributor in the film industry chain, taking on the responsibility of film promotion and distribution. This is a relatively large business, and also a good opportunity to increase our influence in the industry."

Luo Yang had no objection to this.

He also made a light clapping gesture to indicate that Song Wan's business plan was outstanding.

"Finally, there's the advertising business."

Song Wan remained calm and reported, "When our platform has a large user base, we can provide advertising space for film producers, brands, and others, including splash screen ads and homepage recommendation ads. This revenue will be one of the main sources of profit for the website platform in the future."

If these business models can be successfully implemented, there will be a multitude of benefits.

No wonder Song Wan was so eager to persuade Luo Yang to agree to let her acquire shares in Dianping.com.

Because a newly established online ticketing platform needs strong support to quickly capture the market, and Dianping.com, a mature and rapidly expanding platform with tens of millions of registered users and potentially hundreds of millions in the future, is the best background support.

This is a complete business logic line, connecting three companies: Guobao Films, the online ticketing platform, and Dianping.com. Song Wan even considered the future potential of Dianping.com, making a very good investment while completing her own business layout.

This woman is actually quite clever.

No wonder Luo Yang has always recognized her abilities.

They would rather offer her rights, equity, and high salaries, sparing no expense to keep her.

Knowing the future potential of Dianping.com, Luo Yang was certain that this investment would ultimately be very profitable. Even if Song Wan's online ticketing platform lost some money, it would be manageable. Therefore, Luo Yang did not pay much attention to the carefully prepared business plan.

"Whether you directly acquire shares in Damai.cn and own your own online ticketing platform, or acquire Dianping.com and then create a new online ticketing platform, is up to you."

After the business plan presentation, Luo Yang gave instructions: "But let me make this clear from the start: whether it's Plan A or Plan B, the budget is fixed. If there's a budget overrun, you'll have to find your own way to raise the money."

Ultimately, it's about saving money.

After the second group finished their presentations, the third group began to present the projects they had their eye on.

"Chairman, General Manager Song, and colleagues, good afternoon. I am Wu Yonghuai, the leader of the third group of the investment department. I will now report on the project information to you."

As Wu Yonghuai began his opening remarks, he opened the presentation slides.

The third group was responsible for investment targets in the biotechnology and pharmaceutical sectors, so when the PPT was opened, Luo Yang saw the name of a company called Hengrui Medicine.

"Hengrui Medicine Co., Ltd. is a joint-stock company established in April 1997 with the approval of the Jiangsu Provincial People's Government. It was jointly initiated by five initiators, including Lianyungang Hengrui Group Co., Ltd., and is a research and production base specializing in anti-tumor drugs."

The first few pages of the report contained basic information about the company.

"Hengrui Medicine's predecessor was Lianyungang Pharmaceutical Factory, established in 1970, which was initially a local state-owned enterprise. When it was restructured into a joint-stock company in 1997, state-owned capital was one of the founding shareholders and held 62.15% of the shares in the early stage of listing in 2000."

Wu Yonghuai read the contents of the PPT meticulously: "However, at this stage, the company was already state-owned with shares but not controlling shares, and its market-oriented operation was evident. After 2003, as the founder Sun Piaoyang's team gradually gained control through share buybacks and capital increases, state-owned capital gradually withdrew. By around 2010, Hengrui Medicine had completely broken away from the state-owned system and become a wholly privately owned listed company."

"A private pharmaceutical company."

While listening to the report, Luo Yang let his thoughts wander.

He knew the names of companies like Fosun Pharma, Ruidekangming, and Yunnan Baiyao, but he didn't seem to have heard of Hengrui Medicine.

What are your fundamental reasons for being optimistic about this company's prospects?

Luo Yang couldn't recall the company's name, so he asked a question after regaining his senses.

“We investigated Hengrui Medicine’s financial information over the past three years. The data shows that the company achieved a net profit of 4.92 million yuan in 2009 (basic earnings per share of 0.7617 yuan), an increase of 73.67% over the same period of the previous year.”

After hearing Luo Yang's question, Wu Yonghuai immediately flipped through the PPT slides.

"Hengrui Medicine's average sales growth rate over the past three years was 26.83%, ranking 557th out of 1710 listed companies and 22nd out of 90 in the pharmaceutical industry. Its expansion strategy is reasonable."

As he explained, he used a laser pointer to highlight key parts of the report.

"In particular, several financial indicators show that the data is outstanding."

Wu Yonghuai stated, "Regarding EPS growth, Hengrui Medicine's past EPS growth rate was 12.36%, ranking 785th out of 1710 listed companies, and 51st out of 90 in the pharmaceutical industry, highlighting the company's reasonable and excellent growth data."

"In terms of profitability indicators, Hengrui Medicine's average profit growth rate over the past three years was 43.21%, ranking 567th out of 1710 listed companies and 38th out of 90 in the pharmaceutical industry, highlighting its reasonable and excellent profitability data."

"In terms of EPS stability, Hengrui Medicine's past EPS stability ranked 699th out of 1710 among all listed companies, and 38th out of 90 in the pharmaceutical industry, highlighting the company's stable and reasonable operations and excellent data."

"Based on data from various sources, our investment team unanimously believes that this is a pharmaceutical company with great growth potential and is worth long-term investment."

At this point, other reporting content becomes irrelevant.

"Mr. Song, what is the underlying logic behind our investment in these non-startup companies?"

Luo Yang looked at Song Wan and said, "While you were in charge of the investment department, you also served as the group's vice president. You should know that we have no presence in the biotechnology and pharmaceutical industries. What is the reason for suddenly getting involved in this area?"

His questioning was perfectly reasonable.

If it were CATL instead, and Luo Yang didn't have Jiang Yuanshan, a father-in-law who makes new energy batteries, but his industrial layout included a new energy vehicle manufacturing sector, then it would be perfectly reasonable for the investment department to pay attention to such a manufacturing company.

Just like the charging pile projects that were presented earlier, they were related to Luoyang's industrial layout and had good market prospects, which is why they were approved.

Now, a pharmaceutical company has suddenly appeared, one that Luo Yang doesn't recall having any connection to, and which has absolutely no relation to his business strategy.
"I just wanted to see if you have any plans or needs in this area."

Song Wan wasn't worried about Luo Yang's questioning at all, and calmly replied, "President Luo, your assets will definitely increase tenfold, or even dozens of times, in a few years. A big boss like you will be interested in biotechnology and medical resources. Making some arrangements now is also for your own convenience, your family's convenience, and the convenience of your many relatives and friends in the future. Of course, if President Luo is not interested in this area, the responsibilities of the three groups can be adjusted in the future."

Luo Yang: "."

She can make this sound so wonderful!
But Luo Yang was still tempted.

"Even if it's as you say, the three groups should be targeting hospitals or biotechnology companies."

Luo Yang pointed to the PPT projected on the wall and said, "Why would I care about a pharmaceutical company that produces anti-tumor drugs?"

"From a purely investment perspective."

Song Wan picked up the laser pointer in front of her and pointed to the financial indicators on the PPT, saying, "This pharmaceutical company's market value is less than 500 billion yuan now, but according to our analysis, the company's market value will definitely exceed 1000 billion yuan or even higher in the next five years. Isn't a company with an annual return on investment of more than 20% worth our investment department's attention?"

At this point, not only did Song Wan underestimate the company, but even as a reborn individual, Luo Yang knew nothing about it.

Five years later, in 2017, Hengrui Medicine's market value exceeded 200 billion yuan, and eight years later, it exceeded 500 billion yuan.

Industry insiders believe that this company will definitely reach a scale of trillions in the next few years.

(End of this chapter)